Profiling gene expression reveals insights into pulmonary response to aerosolized botulinum toxin type A exposure in mice

Journal of Applied Toxicology ◽

10.1002/jat.4140 ◽

2021 ◽

Author(s):

Duo Su ◽

Changjiao Gan ◽

Zhouguang Jiao ◽

Mengyun Deng ◽

Sha Li ◽

...

Keyword(s):

Gene Expression ◽

Botulinum Toxin ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Pulmonary Response

Download Full-text

Faculty Opinions recommendation of [CONFERENCE POSTER]: Peripheral administration of botulinum toxin type A decreases exaggerated neurotransmitter release and reverses neuropathy-induced gene expression in trigeminal ganglia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1347966.819067 ◽

2009 ◽

Author(s):

Ana Recober ◽

Eric Kaiser

Keyword(s):

Gene Expression ◽

Botulinum Toxin ◽

Neurotransmitter Release ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Trigeminal Ganglia

Download Full-text

Comparison Between Intramuscular and Perimuscular Injections of Botulinum Toxin Type A

Yearbook of Plastic and Aesthetic Surgery ◽

10.1016/s1535-1513(08)70562-9 ◽

2008 ◽

Vol 2008 ◽

pp. 97

Author(s):

P. McKinney

Keyword(s):

Botulinum Toxin ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type

Download Full-text

Top-Accessed Article: Notalgia Paresthetica Treated With Botulinum Toxin Type A

Archives of Dermatology ◽

10.1001/archdermatol.2010.285 ◽

2010 ◽

Vol 146 (11) ◽

Author(s):

Gil Yosipovitch

Keyword(s):

Botulinum Toxin ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Notalgia Paresthetica

Download Full-text

Hip development in children with cerebral palsy and adductor spasticity treated with botulinum toxin type A: A two-year follow-up

Neuropediatrics ◽

10.1055/s-0029-1215844 ◽

2008 ◽

Vol 39 (05) ◽

Author(s):

NH Jung ◽

F Heinen ◽

A Reissig ◽

B Westhoff ◽

S Berweck ◽

...

Keyword(s):

Cerebral Palsy ◽

Botulinum Toxin ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Children With Cerebral Palsy

Download Full-text

Low rate of neutralising antibody formation to botulinum toxin type A in the course of treatment of primary axillary hyperhidrosis

Aktuelle Neurologie ◽

10.1055/s-2005-919411 ◽

2005 ◽

Vol 32 (S 4) ◽

Author(s):

M Naumann ◽

H Hamm ◽

D Glaser ◽

S Daggett ◽

C Kumar ◽

...

Keyword(s):

Botulinum Toxin ◽

Antibody Formation ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Axillary Hyperhidrosis ◽

Download Full-text

Botulinum Toxin Type A Therapy in Chronic Headache Patients

The Korean Journal of Pain ◽

10.3344/kjp.2005.18.1.29 ◽

2005 ◽

Vol 18 (1) ◽

pp. 29

Author(s):

Dong Eon Moon ◽

Young Eun Moon ◽

Shi Hyeon Kim ◽

Eun Sung Kim

Keyword(s):

Botulinum Toxin ◽

Chronic Headache ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Headache Patients

Download Full-text

Intra detrusor injections of botulinum toxin type A in children with spina bifida: a multicentric study

10.26226/morressier.59b63e41d462b8029238978e ◽

2017 ◽

Author(s):

Juliette Hascoet

Keyword(s):

Botulinum Toxin ◽

Spina Bifida ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Multicentric Study

Download Full-text

Faculty Opinions recommendation of Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1066975.519943 ◽

2007 ◽

Author(s):

Jeanette Pitts

Keyword(s):

Botulinum Toxin ◽

Patient Reported Outcomes ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Patient Reported

Download Full-text

Faculty Opinions recommendation of Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1099029.555222 ◽

2008 ◽

Author(s):

Rodolfo Testa

Keyword(s):

Botulinum Toxin ◽

Chronic Inflammation ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Acute Injury ◽

Neuropeptide Release ◽

Download Full-text

Faculty Opinions recommendation of Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1138002.595110 ◽

2008 ◽

Author(s):

Troels Jensen

Keyword(s):

Neuropathic Pain ◽

Botulinum Toxin ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Chronic Neuropathic Pain ◽

Analgesic Effects

Download Full-text